• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.31 Down 0.29(4.39%) Jan 30, 4:00PM EST
    |After Hours : 6.31 0.00 (0.00%) Jan 30, 4:50PM EST
    Add to Portfolio
    Prev Close:6.60
    Open:6.52
    Bid:6.10 x 200
    Ask:N/A
    1y Target Est:14.50
    Beta:2.86
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:6.30 - 6.66
    52wk Range:4.95 - 27.63
    Volume:1,839,640
    Avg Vol (3m):2,705,800
    Market Cap:345.04M
    P/E (ttm):N/A
    EPS (ttm):-1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 4.39%345.04M
    PENCUp 1.43%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,062.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.34
    Quarterly EPS Est (Dec-14) :-0.34
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-0.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback